Skip to content

Growth Mindset Psychoeducation for Modifiable Risk Factors for CMD

The Effect of Growth Mindset Psychoeducation on Modifiable Risk Factors for Common Mental Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03707522
Enrollment
162
Registered
2018-10-16
Start date
2018-06-19
Completion date
2018-12-21
Last updated
2019-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Anxiety

Brief summary

The present study aims to determine the effect of presenting psychoeducation emphasizing growth-mindset, and information on modifiable risk factors (e.g., social contact, physical activity) on engagement with modifiable risk factors. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention.

Interventions

BEHAVIORALGrowth mindset

10 minute interactive article describing neuroplasticity

BEHAVIORALModifiable risk factor (MRF) information

10 minute interactive article describing modifiable risk factors for depression and anxiety

BEHAVIORALControl

10 minute interactive article describing activity scheduling

Sponsors

University of Nevada, Reno
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* College freshmen

Exclusion criteria

* Not fluent in English

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)3 months9-item questionnaire associated containing one item for each symptom of MDD as specified by the DSM. Items consist of a 4-point Likert scale (0=Not at all to 3=Nearly every day). Minimum score is 0, maximum score is 27. Higher scores indicate greater depression severity.
Generalized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)3 months7-item scale, common, brief measure of anxiety symptom severity. Items consist of a 4-point Likert scale (0=Not at all to 3=Nearly every day). Minimum score is 0, maximum score is 21. Higher scores indicate greater anxiety symptom severity.

Secondary

MeasureTime frameDescription
Cognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003)3 monthsThe scale contains 31 items assessing cognitive avoidance and behavioral avoidance of social and non-social avoidance. The scale uses a 5-item Likert scale (1=Not at all true for me to 5=Extremely true for me). Total scale range from 0-155. The behavioral social factor contains 8 items. Items are summed. Minimum score is 8, maximum score is 40. The cognitive nonsocial scale contains 10 items. Minimum score is 10. Maximum score is 50. The cognitive social subscale consists of 7 items. Minimum score is 7, maximum score is 35. The behavioral nonsocial subscale consists of 6 items. Minimum score is 6, maximum score is 30. Higher scores indicate higher levels of avoidance.
Substance Use Measure (Lee et al., 2015)3 months3-item substance use measure including frequency of alcohol use, cigarette use and drug use. Items are measured using a five-point Likert scale (1=never or not at all to 5=almost always). The scale is scored by summing items. Minimum score is 3, maximum score is 15. Higher scores indicate more frequent substance use.
Positive Reframing; Brief COPE (B-COPE; Carver, 1997)3 months28-item scale assessing various dimensions of healthy and unhealthy coping. This include 14 subscales: self-distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, behavioral disengagement, venting, positive reframing, planning, humor, acceptance, religion, and self-blame. Each subscale consists of two items. Subscales are scored by summing items. Scale consists of 4-item Likert scale (1=I haven't been doing this at all to 4 I've been doing this a lot). Minimum score is 2, maximum score is 8 on each subscale. Higher scores indicate greater use of coping strategy. Positive reframing subscale was used.

Countries

United States

Participant flow

Recruitment details

College students recruited via e-mail

Participants by arm

ArmCount
Growth Mindset + MRF Information
Online growth mindset interactive article followed by equal length interactive article describing the relationship between modifiable risk factors (MRF) and mental health outcomes Growth mindset: 10 minute interactive article describing neuroplasticity Modifiable risk factor (MRF) information: 10 minute interactive article describing modifiable risk factors for depression and anxiety
31
Control + MRF Information
Online daily activity scheduling interactive article (control) followed by equal length interactive article describing the relationship between modifiable risk factors and mental health outcomes Modifiable risk factor (MRF) information: 10 minute interactive article describing modifiable risk factors for depression and anxiety Control: 10 minute interactive article describing activity scheduling
36
Control + Growth Mindset
Online growth mindset interactive article followed by equal length online daily activity scheduling interactive article (control) Growth mindset: 10 minute interactive article describing neuroplasticity Control: 10 minute interactive article describing activity scheduling
52
Control + Control
2 doses online daily activity scheduling interactive article (control) Control: 10 minute interactive article describing activity scheduling
43
Total162

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyLost to Follow-up24274136

Baseline characteristics

CharacteristicTotalGrowth Mindset + MRF InformationControl + MRF InformationControl + ControlControl + Growth Mindset
Age, Continuous18.04 years
STANDARD_DEVIATION 0.19
18.06 years
STANDARD_DEVIATION 0.25
18.00 years
STANDARD_DEVIATION 0
18.07 years
STANDARD_DEVIATION 0.26
18.02 years
STANDARD_DEVIATION 0.14
GAD-7 (Anxiety severity)6.27 units on a scale
STANDARD_DEVIATION 5.78
5.97 units on a scale
STANDARD_DEVIATION 5.31
5.25 units on a scale
STANDARD_DEVIATION 5.82
8.26 units on a scale
STANDARD_DEVIATION 6.53
5.52 units on a scale
STANDARD_DEVIATION 5.08
PHQ-9 (Depression severity)6.89 units on a scale
STANDARD_DEVIATION 6.43
7.06 units on a scale
STANDARD_DEVIATION 6.01
5.28 units on a scale
STANDARD_DEVIATION 5.22
9.65 units on a scale
STANDARD_DEVIATION 7.93
5.62 units on a scale
STANDARD_DEVIATION 5.34
Race/Ethnicity, Customized
Race/ethnciity
Asian/Pacific Islander
23 Participants4 Participants5 Participants5 Participants9 Participants
Race/Ethnicity, Customized
Race/ethnciity
Black or African-American
5 Participants1 Participants1 Participants0 Participants3 Participants
Race/Ethnicity, Customized
Race/ethnciity
Hispanic or Latino
24 Participants5 Participants5 Participants8 Participants6 Participants
Race/Ethnicity, Customized
Race/ethnciity
Native American or American Indian
3 Participants0 Participants2 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race/ethnciity
Other
12 Participants4 Participants1 Participants3 Participants4 Participants
Race/Ethnicity, Customized
Race/ethnciity
White
95 Participants17 Participants22 Participants27 Participants29 Participants
Region of Enrollment
United States
162 Participants31 Participants36 Participants43 Participants52 Participants
Sex: Female, Male
Female
43 Participants7 Participants11 Participants14 Participants11 Participants
Sex: Female, Male
Male
119 Participants24 Participants25 Participants29 Participants41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 00 / 0

Outcome results

Primary

Generalized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)

7-item scale, common, brief measure of anxiety symptom severity. Items consist of a 4-point Likert scale (0=Not at all to 3=Nearly every day). Minimum score is 0, maximum score is 21. Higher scores indicate greater anxiety symptom severity.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Growth Mindset + MRF InformationGeneralized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)3.67 units on a scaleStandard Deviation 5.75
Control + MRF InformationGeneralized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)4.43 units on a scaleStandard Deviation 6.29
Control + Growth MindsetGeneralized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)6.90 units on a scaleStandard Deviation 4.68
Control + ControlGeneralized Anxiety Disorder-7 (GAD-7; Spitzer, Kroenke, Williams & Lowe, 2006)12.14 units on a scaleStandard Deviation 7.69
Primary

Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)

9-item questionnaire associated containing one item for each symptom of MDD as specified by the DSM. Items consist of a 4-point Likert scale (0=Not at all to 3=Nearly every day). Minimum score is 0, maximum score is 27. Higher scores indicate greater depression severity.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Growth Mindset + MRF InformationPatient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)5.50 units on a scaleStandard Deviation 7.34
Control + MRF InformationPatient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)4.57 units on a scaleStandard Deviation 3.15
Control + Growth MindsetPatient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)6.70 units on a scaleStandard Deviation 3.37
Control + ControlPatient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001)13.14 units on a scaleStandard Deviation 7.52
Secondary

Cognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003)

The scale contains 31 items assessing cognitive avoidance and behavioral avoidance of social and non-social avoidance. The scale uses a 5-item Likert scale (1=Not at all true for me to 5=Extremely true for me). Total scale range from 0-155. The behavioral social factor contains 8 items. Items are summed. Minimum score is 8, maximum score is 40. The cognitive nonsocial scale contains 10 items. Minimum score is 10. Maximum score is 50. The cognitive social subscale consists of 7 items. Minimum score is 7, maximum score is 35. The behavioral nonsocial subscale consists of 6 items. Minimum score is 6, maximum score is 30. Higher scores indicate higher levels of avoidance.

Time frame: 3 months

Population: 1 participant completed primary but not secondary outcome measure

ArmMeasureValue (MEAN)Dispersion
Growth Mindset + MRF InformationCognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003)52.1 units on a scaleStandard Deviation 19.6
Control + MRF InformationCognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003)57.3 units on a scaleStandard Deviation 22.9
Control + Growth MindsetCognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003)54.8 units on a scaleStandard Deviation 17.8
Control + ControlCognitive and Behavioral Avoidance Scale (CBAS, Ottenbreit & Dobson, 2003)74.3 units on a scaleStandard Deviation 25.2
Secondary

Positive Reframing; Brief COPE (B-COPE; Carver, 1997)

28-item scale assessing various dimensions of healthy and unhealthy coping. This include 14 subscales: self-distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, behavioral disengagement, venting, positive reframing, planning, humor, acceptance, religion, and self-blame. Each subscale consists of two items. Subscales are scored by summing items. Scale consists of 4-item Likert scale (1=I haven't been doing this at all to 4 I've been doing this a lot). Minimum score is 2, maximum score is 8 on each subscale. Higher scores indicate greater use of coping strategy. Positive reframing subscale was used.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Growth Mindset + MRF InformationPositive Reframing; Brief COPE (B-COPE; Carver, 1997)2.9 units on a scaleStandard Deviation 1.1
Control + MRF InformationPositive Reframing; Brief COPE (B-COPE; Carver, 1997)2.9 units on a scaleStandard Deviation 1.1
Control + Growth MindsetPositive Reframing; Brief COPE (B-COPE; Carver, 1997)2.4 units on a scaleStandard Deviation 0.83
Control + ControlPositive Reframing; Brief COPE (B-COPE; Carver, 1997)3.2 units on a scaleStandard Deviation 1
Secondary

Substance Use Measure (Lee et al., 2015)

3-item substance use measure including frequency of alcohol use, cigarette use and drug use. Items are measured using a five-point Likert scale (1=never or not at all to 5=almost always). The scale is scored by summing items. Minimum score is 3, maximum score is 15. Higher scores indicate more frequent substance use.

Time frame: 3 months

Population: 2 participants completed primary but not secondary outcomes

ArmMeasureValue (MEAN)Dispersion
Growth Mindset + MRF InformationSubstance Use Measure (Lee et al., 2015)3.9 units on a scaleStandard Deviation 1.5
Control + MRF InformationSubstance Use Measure (Lee et al., 2015)3.2 units on a scaleStandard Deviation 0.7
Control + Growth MindsetSubstance Use Measure (Lee et al., 2015)3.6 units on a scaleStandard Deviation 1.3
Control + ControlSubstance Use Measure (Lee et al., 2015)4.9 units on a scaleStandard Deviation 2.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026